Medicenna Therapeutics Corp.
MDNAF
$0.32
$0.0310.35%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -74.02% | -62.87% | -49.80% | -42.38% | 37.79% |
| Total Receivables | -48.44% | 7.73% | -17.57% | -1.33% | 118.12% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 16.31% | 49.01% | 8.59% | -15.22% | -35.33% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -69.52% | -57.67% | -46.96% | -40.28% | 39.12% |
|
|
|||||
| Total Current Assets | -69.52% | -57.67% | -46.96% | -40.28% | 39.12% |
| Net Property, Plant & Equipment | -41.59% | -38.24% | -39.97% | 407.80% | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -6.63% | -4.89% | -12.00% | -8.71% | -14.01% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -69.25% | -57.47% | -46.86% | -39.91% | 39.74% |
|
|
|||||
| Total Accounts Payable | 85.29% | 137.34% | 77.87% | -9.50% | 22.93% |
| Total Accrued Expenses | -66.19% | -57.66% | -13.89% | 171.79% | 100.19% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 36.95% | 70.50% | 87.76% | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 27.21% | 59.46% | 50.90% | -69.70% | 45.93% |
|
|
|||||
| Total Current Liabilities | 27.21% | 59.46% | 50.90% | -69.70% | 45.93% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -53.14% | -45.11% | -41.37% | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -90.12% | -82.08% | -68.02% | -- | -59.76% |
| Total Liabilities | -33.62% | -51.37% | -41.26% | -46.13% | -37.25% |
|
|
|||||
| Common Stock & APIC | 12.52% | 14.50% | 7.72% | 12.33% | 7.62% |
| Retained Earnings | -19.30% | -16.35% | -8.72% | -12.29% | -4.66% |
| Treasury Stock & Other | -98.34% | -99.43% | -99.50% | -99.64% | 48,770.00% |
| Total Common Equity | -86.58% | -62.65% | -50.46% | -35.79% | 246.55% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -86.58% | -62.65% | -50.46% | -35.79% | 246.55% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -86.58% | -62.65% | -50.46% | -35.79% | 246.55% |
|
|
|||||